Related Experiment Videos

Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls

Insights

Diabetic children show higher serum apolipoprotein A-I levels than healthy children. Correlations between apolipoproteins and serum lipids differ in diabetic versus healthy children.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Biochemistry
  • Lipid Metabolism

Background:

  • Diabetes mellitus in children can affect lipid profiles.
  • Apolipoproteins are crucial components of lipoproteins and play roles in lipid transport.
  • Understanding apolipoprotein levels in pediatric diabetes is important for assessing cardiovascular risk.

Purpose of the Study:

  • To compare serum concentrations of apolipoprotein A-I (apo A-I), apolipoprotein A-II (apo A-II), and apolipoprotein B (apo B) in diabetic children and healthy controls.
  • To investigate the correlations between apolipoproteins and serum lipids in both groups.

Main Methods:

  • Serum samples were collected from 28 diabetic children (ages 3-16) and 14 healthy matched controls.
  • Concentrations of apo A-I, apo A-II, and apo B were measured.
  • Serum cholesterol levels were also determined.
  • Statistical analyses were performed to compare groups and assess correlations.

Main Results:

  • Diabetic children had significantly higher serum apo A-I concentrations compared to healthy children (p < 0.02).
  • Serum apo A-II and apo B concentrations did not significantly differ between diabetic and healthy children.
  • In healthy children, serum cholesterol strongly correlated with apo A-I and apo A-II.
  • These correlations were not observed in diabetic children, suggesting altered apolipoprotein/lipoprotein lipid relationships.

Conclusions:

  • Pediatric diabetes is associated with elevated serum apo A-I levels.
  • The relationship between apolipoproteins and serum lipids appears altered in diabetic children compared to their healthy peers.
  • Further research is warranted to elucidate the implications of these altered lipid-apolipoprotein interactions in pediatric diabetes.

Related Concept Videos